Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis

Background: Antiangiogenic therapy with anti-vascular endothelial growth factor (VEGF) is commonly used to treat diabetic macular edema (DME), which can reduce edema, improve vision, and prevent further visual loss. There is little head-to-head trial data to guide the selection of an individual VEGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xian, He, Xiaoning, Qi, Fang, Liu, Jia, Wu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260109/
https://www.ncbi.nlm.nih.gov/pubmed/35814207
http://dx.doi.org/10.3389/fphar.2022.876386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260109/
https://www.ncbi.nlm.nih.gov/pubmed/35814207
http://dx.doi.org/10.3389/fphar.2022.876386

Ejemplares similares